Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;49(4):287-9.
doi: 10.4103/0019-5545.37671.

A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period

Mehmet Ustündağ  1 , Murat Orak, Cahfer Güloğlu, Mustafa Burak Sayhan, Mahmut Taş
Affiliations

A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period

Mehmet Ustündağ et al. Indian J Psychiatry. 2007 Oct.

Abstract

Neuroleptic malignant syndrome (NMS) is a life-threatening medical complication that occurs as a result of dopaminergic receptor blockage in nigrostriatal pathways. This syndrome is mainly accepted to be an idiosyncratic reaction for antipsychotic medications. Incidence of NMS induced by olanzapine - an atypical antipsychotic - is extremely rare. However, there has been contradiction on postpartum period as a risk factor for NMS. This case is of interest due to the fact that it happens on postpartum period and is induced by olanzapine. We aimed in this study to evaluate the successfully cured case of neuroleptic malignant syndrome induced by olanzapine in postpartum period with the literature view.

Keywords: Emergency department; neuroleptic malignant syndrome; olanzapine; postpartum period.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Shad P. Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome. J Clin Psychopharmacol. 1998;18:346–7. - PubMed
    1. Rasmussen KG. Risk factors for neuroleptic malignant syndrome. Am J Psychiatry. 1998;155:1639–40. - PubMed
    1. John M, Davýs MD, Philip G, et al. Neuroleptic malignant syndrome. In: Dunner DL, editor. Current psychiatric therapy. Philadelphia: Harcourt Broce Jovanich Ýnc; 1993. pp. 170–5.
    1. Margetic B, Aukst-Margetic B. Neuroleptic malignant syndrome and clozapine withdrawal at the same time? Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:145–7. - PubMed
    1. Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65:464–70. - PubMed